NCT07263919
- Conditions
- Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Locations
-
- The Second Affiliated Hospital of Air Force Medical University Xi'an, China
Clinical trial condition
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
Explore clinical trials studying Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
2 public trials
1 recruiting study
Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma trial results
Active, Not Recruiting
Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
NCT04848753
- Conditions
- Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma
- Locations
-
- The Firest Affiliated Hospital of bengbu Medical College Bengbu, Anhui, China
- Anhui provincial hospital Hefei, Anhui, China
- The Second Hospital of anhui Medical University Hefei, Anhui, China
- Jiangmen central Hospital Jiangmen, Guangdong, China